X0306 5 2019-12-31 0 1 0001653821 CEN BIOTECH INC CENBF 0001736937 Tarrabain Alex 300-3295 QUALITY WAY WINDSOR, ONTARIO, CANADA A6 N8T 3R9 ONTARIO, CANADA 1 1 Chief Financial Officer Common Stock 2019-01-16 4 J 0 L 3000 0 A 1421942 D Common Stock 2019-02-16 4 J 0 L 3000 0 A 1421942 D Common Stock 2019-03-16 4 J 0 L 3000 0 A 1421942 D Common Stock 2019-04-16 4 J 0 L 3000 0 A 1421942 D Common Stock 2019-05-16 4 J 0 L 3000 0 A 1421942 D Common Stock 2019-05-16 4 A 0 L 1250000 0 A 1421942 D Common Stock 2019-06-16 4 J 0 L 3000 0 A 1421942 D Common Stock 2019-07-16 4 J 0 L 3000 0 A 1421942 D Common Stock 2019-08-16 4 J 0 L 3000 0 A 1421942 D Common Stock 2019-09-16 4 J 0 L 3000 0 A 1421942 D Common Stock 2019-10-16 4 J 0 L 3000 0 A 1421942 D Common Stock 2019-11-16 4 J 0 L 3000 0 A 1421942 D Common Stock 2019-12-16 4 J 0 L 3000 0 A 1421942 D 36,000 shares of common stock of the issuer were issued as consideration for extending the maturity date of a promissory note dated January 14, 2018 and were acquired in increments of 3,000 shares on the following dates: 01/16/2019; 02/16/2019; 03/16/2019; 04/16/2019; 05/16/2019; 06/16/2019; 07/16/2019; 08/16/2019; 09/16/2019; 10/16/2019; 11/16/2019 and 12/16/2019. Includes 30,000 shares issuable upon conversion of a convertible promissory note held by the reporting person which was issued on October 26, 2016 in the amount of $48,000. 1,250,000 shares of common stock of the issuer were granted by the issuer on May 16, 2019, pursuant to a restricted stock agreement pursuant to the issuer's equity compensation plan and the issuance was approved by the issuer's full board of directors. /s/ Alex Tarrabain 2021-04-28